SIALIDOSIS

 

SIALIDOSIS

 

DEFINITION:

A neurodegenerative disorder characterized by myoclonic seizures, tonic-clonic seizures, progressive neurologic dysfunction (ataxia), and macular cherry-red spots.

EPIDEMIOLOGY:

  • incidence: rare
  • age of onset:
    • neonatal to adolescence (depends on the Type)
  • risk factors:
    • familial - autosomal recessive
      • chrom.#: ?6p21.3
      • gene: alpha-N-acetylneuraminidase
    • M = F

PATHOGENESIS:

1. Background

  • one of the 5 major conditions that account for the majority of cases of "Progressive Myoclonus Epilepsies"
  • considered to be a lysosomal storage disease
  • the difference between Sialidosis and Galactosialidosis is that in the former there is a deficiency of alpha-N-acetylneuraminidase while in the latter there is a combined deficiency of alpha-N-acetylneuraminidase and beta-galactosidase
  • alpha-N-acetylneuraminidases (there may be more than one form) normally cleave terminal sialic acid residues of several oligosaccharides, glycoproteins, and gangliosides

2. Genetic Defect

  • genetic defect -> deficiency of alpha-N-acetylneuraminidase -> accumulation of sialyloligosaccharides and sialylglycopeptides in lymphocytes, fibroblasts, bone marrow cells, Kupffer cells (liver), Schwann cells, etc.
  • the difference between Types I and II Sialidosis is only the Type II form is associated with abnormal somatic features - coarse facies and dysostosis multiplex

TYPES:

  • Type I: "Cherry-Red Spot-Myoclonus Syndrome" (CRSM)
  • Type II: Neonatal Onset
  • Type II: Infantile Onset
  • Type II: Juvenile Onset (Galactosialidosis)
  • CLINICAL FEATURES:

    1. Neurological Manifestations

    1. Type I

    • onset in adolescence:

    1. Initial

    1. Myoclonic Seizures

    • generalized affecting the extremities
    • triggered by voluntary movement, touch, sound, smoking, menstrual cycle
    • progressive -> nonambulatory

    2. Macular Cherry-Red Spot

    • progressive loss of visual acuity
    • gradual loss of vision

    2. Later

    • tonic-clonic seizures
    • ataxia with gait disturbances
    • mild peripheral neuropathy ("burning feet")
    • usually not associated with dementia
    • ocular manifestations:
      • impaired colour vison or night blindness
      • lens opacities
      • nystagmus
    • normal life spam-spam-spam

    2. Type II - Neonatal Onset

    1. Initial (at birth)

    • hydrops fetalis with:
      • ascites
      • hepatomegaly +/- splenomegaly
      • inguinal hernia
      • facial edema
      • pericardial effusion
    • corneal opacifications
    • stillborn or death at an early age

    3. Type II - Infantile Onset

    1. Initial (at birth)

    • range from normal to minimal abnormalities to neonates with ascites and hydrops fetalis

    2. Later (end of 1st decade)

    • mucopolysaccharidosis-like phenotypes
      • visceromegaly
      • mental retardation (but not progressive dementia)
      • dysostosis multiplex
      • progressive
    • macular cherry-red spots
    • myoclonic seizures
    • ataxia
    • death in the 2nd decade

    INVESTIGATIONS:

    1. Imaging Studies

    1. CT/MRI

    • generalized cerebral atrophy

    2. Skeletal X-Rays

    • Type II - dysostosis multiplex
    • Type II - Neonatal Form
      • stippling of epiphyses
      • periosteal cloaking

    2. Pathology

    1. Sialyloligosaccharides/Sialylglycopeptides

    • detected by light microscopy
    • periodic acid-Schiff-positive inclusions (vacuolations) within cells throughout the body
    • represents the lysosomal storage material

    3. Urine

    • increased secretion of sialyloligosaccharides and sialylglycopeptides detected by thin-layer chromatography

    4. Diagnostic

    • deficiency of alpha-N-acetylneuraminidase activity in leukocytes or cultured fibroblasts
    • prenatal:
      • deficiency of alpha-N-acetylneuraminidase activity in cultured chorionic villi or amniocytes

    MANAGEMENT:

    1. Supportive

    • no treatment available for the disease
    • multidisciplinary approach to ongoing problems
      • Paediatrics, Neurology, Ortho, PT, OT, Ophthalmology
      • seizure control
        • myoclonic seizures very difficult to control

     

    Pediatric Database - SIALIDOSIS

    Pediatric Organization - Pedbase [at] Gmail.com